Bionano Genomics (BNGO) Income from Non-Controlling Interests (2022)

Bionano Genomics (BNGO) reported Income from Non-Controlling Interests of -$1.1 million for Q1 2022.

Bionano Genomics (BNGO) Income from Non-Controlling Interests (2022) Analysis & Trends

Bionano Genomics (BNGO) has 1 years of Income from Non-Controlling Interests data on file, last reported at -$1.1 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Intuitive Surgical 126.72 Bn 121.51 Bn 1.96 Bn -18.70 Mn
2 Becton Dickinson 44.88 Bn 44.07 Bn 2.15 Bn -
3 Alcon 33.19 Bn 31.53 Bn 1.53 Bn -
4 Medline 32.91 Bn 30.67 Bn 1.84 Bn 110.00 Mn
5 Resmed 29.46 Bn 27.80 Bn 890.98 Mn -
6 West Pharmaceutical Services 23.22 Bn 22.79 Bn 329.20 Mn -
7 Solventum 14.06 Bn 13.50 Bn 1.10 Bn -
8 Cooper Companies 13.85 Bn 13.71 Bn 735.40 Mn -
9 Align Technology 12.13 Bn 11.07 Bn 736.59 Mn -
10 Bionano Genomics 12.08 Mn -1.61 Mn 3.25 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 -1.10 Mn